IRD vs PG
Opus Genetics, Inc. (IRD) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
IRD currently screens at market cap $35.7M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the IRD and PG stock pages for the full models.
Not investment advice.